Skip to content

Meet us at COP31Read more

Bone Biologics Corp Sustainability Reports

Bone Biologics Corp. is a medical device company focused on bone regeneration in spinal fusion using recombinant human protein solutions. Its lead product platform centers on the rhNELL-1 growth factor growth device targeted for surgical use.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

4 reports from 2014 to 2025